No Data
No Data
No Data
No Data
No Data
Pulmonx(LUNG.US) Officer Sells US$8,868.16 in Common Stock
$Pulmonx(LUNG.US)$ Officer Rose Geoffrey Beran sold 1,184 shares of common stock on Apr 22, 2024 at an average price of $7.49 for a total value of $8,868.16.Source: Announcement What is statement of c
Futu NewsApr 25 06:58
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
REDWOOD CITY, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx"), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial
GlobeNewswireApr 11 04:05
Insider Sellers Might Regret Selling Pulmonx Shares at a Lower Price Than Current Market Value
Pulmonx Corporation's (NASDAQ:LUNG) value has fallen 15% in the last week, but insiders who sold US$661k worth of stock over the last year have had less success. Given that the average selling price
Simply Wall StApr 5 18:44
Navigating 6 Analyst Ratings For Pulmonx
Analysts' ratings for Pulmonx (NASDAQ:LUNG) over the last quarter vary from bullish to bearish, as provided by 6 analysts.The table below provides a snapshot of their recent ratings, showcasing how se
BenzingaApr 4 02:00
Pulmonx Price Target Maintained With a $17.00/Share by Piper Sandler
Pulmonx Price Target Maintained With a $17.00/Share by Piper Sandler
Dow JonesApr 4 00:15
Piper Sandler Reiterates Overweight on Pulmonx, Maintains $17 Price Target
Piper Sandler analyst Jason Bednar reiterates Pulmonx with a Overweight and maintains $17 price target.
Analyst UpgradesApr 4 00:05
No Data
No Data